Is three-year oral pantoprazole administration effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions?
Maintenance oral pantoprazole therapy up to 3 years at dosages of 40-120 mg b.d. was effective and well tolerated in patients with Zollinger-Ellison syndrome and other hypersecretory conditions.
NBI-TUR decreases residual tumour rate significantly when compared to a matched cohort of WL-TUR.